Form 4: Immuneering Corp Director Diana Hausman Acquires Stock Options
SEC Form 4 Filing
Director Diana Hausman acquired 33,350 stock options in Immuneering Corp on June 12, 2024.
Summary
- On June 12, 2024, Diana Hausman, a director of Immuneering Corp, acquired 33,350 stock options.
- The options have an exercise price of $1.54.
- The options vest in equal monthly installments over one year, starting July 12, 2024, and will be fully vested by June 12, 2025, or the date of the 2025 annual meeting of stockholders, whichever comes first.
- The options expire on June 12, 2034.
- Following the transaction, Hausman directly owns 33,350 derivative securities.
Sentiment
Score: 6
Explanation: The sentiment is neutral to slightly positive. The acquisition of stock options by a director can be seen as a sign of confidence, but it's a routine transaction.
Positives
- A director's acquisition of stock options can be seen as a positive sign, indicating confidence in the company's future performance.
Industry Context
Form 4 filings are standard practice and provide transparency into the transactions of company insiders. This filing indicates a director's acquisition of stock options, which is a common form of compensation.
Stakeholder Impact
- The acquisition of stock options by a director could have a slightly positive impact on shareholder sentiment.
Key Dates
| Date | Description |
|---|---|
| 06/12/2024 | Date of transaction: Diana Hausman acquired stock options. |
| 07/12/2024 | Vesting start date: Options vest in equal monthly installments over a one-year period commencing on this date. |
| 06/12/2025 | Options will be fully vested and exercisable on this date, or the date of the 2025 annual meeting of stockholders, whichever comes first. |
| 06/12/2034 | Expiration date of the stock options. |
| 06/13/2024 | Date of signature on the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.